The CTC collaborates with the the Cooperative Trials Group for Neuro-Oncology (COGNO) to conduct high quality clinical trials research evaluating new therapies for the prevention and mitigation of brain tumours.

COGNO was established in 2007 to develop a coordinated, well-structured approach to the management of large-scale multicentre neuro-oncology trials. Its main aim is to conduct investigator-initiated and collaborative group trials addressing important clinical questions in patients with brain tumours. The group is based at the CTC, and is currently collaborating with the CTC to recruit patients to three trials investigating novel therapeutic strategies for patients with glioma and glioblastoma, with three ongoing trials also in process.

For more information contact the Oncology Associate Program Manager (

Brain Cancer